PETER SCHAFER, EXECUTIVE DIRECTOR OF TRANSLATIONAL MEDICINE AT CELGENE, BELIEVES WE ARE AT A TIPPING POINT WHERE THE COLLECTION OF LUPUS GENETIC RESEARCH IS ABOUT TO GIVE WAY TO NEW THERAPEUTIC APPROACHES.
These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed under the Global Network).
Beware of fraudulent and misleading emails being sent by unauthorized persons for job interviews/offers at Celgene Corporation. These messages are being sent to cheat individuals. Celgene never requires any payment to be made by any candidate to Celgene or to any individual or agency as part of our recruitment process. Celgene will never ask for bank account or credit card information pre-hire. Please report any such activity to Frank Marrero.